Lung Kee Group Holdings (HKSE:00255) Other Stockholders Equity: HK$560 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00255 Lung Kee Group Holdings Ltd HKSE:00255
66 GF Score
Price HK$1.40
GF Value HK$1.15
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Lung Kee Group Holdings Other Stockholders Equity?

Lung Kee Group Holdings HKSE:00255 66 Other Stockholders Equity is HK$560 Mil as of Jun. 2026. GuruFocus rates HKSE:00255 with a GF Score™ of 66/100 and a GF Value™ of HK$1.15 (Modestly Overvalued). The stock has 1 warning sign investors should review.

Lung Kee Group Holdings's Other Stockholders Equity for the quarter that ended in Jun. 2026 was HK$560 Mil.

Lung Kee Group Holdings's quarterly Other Stockholders Equity increased from Jun. 2025 (HK$501 Mil) to Dec. 2025 (HK$518 Mil) and increased from Dec. 2025 (HK$518 Mil) to Jun. 2026 (HK$560 Mil).

Lung Kee Group Holdings's annual Other Stockholders Equity declined from Dec. 2023 (HK$506 Mil) to Dec. 2024 (HK$457 Mil) but then increased from Dec. 2024 (HK$457 Mil) to Dec. 2025 (HK$518 Mil).

Lung Kee Group Holdings Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Lung Kee Group Holdings's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lung Kee Group Holdings Other Stockholders Equity Chart

Lung Kee Group Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,208.10 556.62 505.71 457.33 518.23

Lung Kee Group Holdings Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 466.33 457.33 501.50 518.23 560.36
HKSE:00255
66GF Score
Lung Kee Group Holdings Ltd HKSE:00255
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lung Kee Group Holdings Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of HK$560 Mil mean?
Lung Kee Group Holdings (HKSE:00255) has a Other Stockholders Equity of HK$560 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Lung Kee Group Holdings and its competitors.
Is Lung Kee Group Holdings' Other Stockholders Equity too high?
Lung Kee Group Holdings' current Other Stockholders Equity is HK$560 Mil. Overall, Lung Kee Group Holdings has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lung Kee Group Holdings' Other Stockholders Equity compare to ATI and CRS?
Lung Kee Group Holdings' Other Stockholders Equity of HK$560 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for an Industrial Products company?
A good Other Stockholders Equity depends on the Industrial Products industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Lung Kee Group Holdings and its competitors. Lung Kee Group Holdings's current Other Stockholders Equity is HK$560 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lung Kee Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Lung Kee Group Holdings (HKSE:00255) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$1.15, compared to a current price of HK$1.40 — trading 21.7% above its estimated fair value. The current Other Stockholders Equity is HK$560 Mil. Lung Kee Group Holdings' overall GF Score™ is 66/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Lung Kee Group Holdings (HKSE:00255), the current Other Stockholders Equity is HK$560 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lung Kee Group Holdings (HKSE:00255) Overvalued in 2026?

Based on GuruFocus' analysis, Lung Kee Group Holdings stock appears to be overvalued. The current stock price of HK$1.40 is trading 21.7% above its estimated GF Value™ of HK$1.15. GuruFocus considers Lung Kee Group Holdings to be Modestly Overvalued.

Key valuation signals for HKSE:00255:

  • Other Stockholders Equity: HK$560 Mil
  • GF Value™: HK$1.15 vs. price of HK$1.40 (21.7% above fair value)
  • GF Score™: 66/100 with 1 warning sign

No single metric tells the full story. See the HKSE:00255 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lung Kee Group Holdings Business Description

Address No. 1 On Kwan Street, Unit A, 15th Floor, Kings Wing Plaza 2, Sha Tin, New Territories, Hong Kong, HKG
Lung Kee Group Holdings Ltd is an investment holding company that provides corporate management services. Along with its subsidiaries, it is engaged in the manufacturing and marketing of mould bases and related products. Its product offerings include standard and custom-made mould base, mould components, tool and steel products such as plastic and steel mould, hot and cold work steel, precision plates, standard mould inserts, and other materials. The company generates a majority of its revenue from the People's Republic of China and the rest from other markets like Asia, Europe, and America.
66GF Score

Get the complete analysis for HKSE:00255

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.40
Price
HK$1.15
GF Value